Literature DB >> 9294923

Coxsackievirus B epidemiology and public health concerns.

M A Pallansch1.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9294923     DOI: 10.1007/978-3-642-60687-8_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  12 in total

1.  Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.

Authors:  S D Carson; J T Hobbs; S M Tracy; N M Chapman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.

Authors:  Rui Gu; Cristy Stagnar; Lesya Zaichenko; Arlene I Ramsingh
Journal:  Vaccine       Date:  2012-03-29       Impact factor: 3.641

4.  Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Authors:  E Stadnick; M Dan; A Sadeghi; J K Chantler
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Authors:  Patricia E Tam; Melissa L Weber-Sanders; Ronald P Messner
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.

Authors:  Rui Gu; Anae Shampang; Toufic Nashar; Manisha Patil; Deborah H Fuller; Arlene I Ramsingh
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

Review 8.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

9.  Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.

Authors:  Daniel M Potvin; Dennis W Metzger; William T Lee; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B₄.

Authors:  Zhao Liu; Fei Wei; Liang-Jun Chen; Hai-Rong Xiong; Yuan-Yuan Liu; Fan Luo; Wei Hou; Hong Xiao; Zhan-Qiu Yang
Journal:  Molecules       Date:  2013-09-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.